Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guinea Bissau Health Bulletin.
Press releases published on November 5, 2025
November 5, 2025
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
Indeterminate
GlobeNewswire
November 5, 2025
BioAtla to Announce Third Quarter 2025 Financial Results and Provide Business Highlights on November 13, 2025
Indeterminate
GlobeNewswire
November 5, 2025
Beyond Air® Secures Up to $32 Million to Accelerate Growth
Indeterminate
GlobeNewswire
November 5, 2025
Kailera Therapeutics to Participate in Upcoming November Investor Conferences
Indeterminate
GlobeNewswire
November 5, 2025
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 5, 2025
LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Indeterminate
GlobeNewswire
November 5, 2025
23andMe Research Institute Appoints Kael Reicin as Chief Financial Officer
Indeterminate
GlobeNewswire
November 5, 2025
Ardelyx to Participate at the Jefferies Global Healthcare Conference in London
Indeterminate
GlobeNewswire
November 5, 2025
Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025
Indeterminate
GlobeNewswire
November 5, 2025
MannKind Corporation Reports Third Quarter 2025 Financial Results and Provides Business Update
Indeterminate
GlobeNewswire
November 5, 2025
Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights
Indeterminate
GlobeNewswire
November 5, 2025
Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire
November 5, 2025
MediWound to Report Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 5, 2025
Altimmune to Participate in Two Upcoming Investor Conferences
Indeterminate
GlobeNewswire
November 5, 2025
Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates
Indeterminate
GlobeNewswire
November 5, 2025
Crescent Biopharma to Present at November Investor Conferences
Indeterminate
GlobeNewswire
November 5, 2025
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
Indeterminate
GlobeNewswire